Implantable cardioverter-defibrillators.
نویسندگان
چکیده
N Engl J Med 2003;349:1836-47. Copyright © 2003 Massachusetts Medical Society. espite advances in emergency medical systems and in techniques of resuscitation, sudden death from cardiac arrest remains a major public health problem. Most persons who have an out-of-hospital cardiac arrest do not survive. 1,2 Those who are resuscitated may have severe, long-term cognitive impairment and motor impairment due to delays before a stable rhythm could be restored. In the 1970s, motivated by the death of a colleague, Drs. Michel Mirowski and Morton Mower, and their colleagues, developed the concept of an implantable device that could automatically monitor and analyze cardiac rhythm and deliver defibrillating shocks when it detected ventricular fibrillation. 3,4 After years of testing, in 1980 the first clinical implantation was performed in a young woman with recurrent ventricular fibrillation. 5 Subsequently, the implantable cardioverter–defibrillator evolved from a therapy of last resort for patients with recurrent cardiac arrest to a management standard for use in primary prevention (the prevention of a first life-threatening event) and secondary prevention (prevention of a recurrence of a potentially fatal arrhythmia or cardiac arrest) in patients with coronary heart disease.
منابع مشابه
Implantable cardioverter defibrillator during laser transurethral resection of the prostate
Implantable cardioverter defibrillators have been instrumental in the health and safety of patients who are at increased risk of sudden death by ventricular tachycardia or fibrillation. Consensus on the perioperative management of cardiovascular implantable electronic devices has suggested that certain surgical interventions (including transurethral resection of the prostate) may interfere wi...
متن کاملImplantable Cardioverter Defibrillators Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CLINICAL RESEARCH Implantable Cardi...
متن کاملTime-Dependent Changes in Psychosocial Distress in Japanese Patients with Implantable Cardioverter Defibrillators.
This prospective study clarified changes in the mood states of Japanese patients with implantable cardioverter defibrillators as well as factors related to the mood states. Using a longitudinal repeated-measure design, 29 patients with implantable cardioverter defibrillators completed the Profile of Mood States-Short Form Japanese Version questionnaire before discharge and 1, 4, 7, and 13 month...
متن کاملiPad2® Use in Patients With Implantable Cardioverter Defibrillators Causes Electromagnetic Interference: The EMIT Study
BACKGROUND Over 140 million iPads(®) have been sold worldwide. The iPad2(®), with magnets embedded in its frame and Smart Cover and 3G cellular data capability, can potentially cause electromagnetic interference in implantable cardioverter defibrillators. This can lead to potentially life-threatening situations in patients. The goal of this study was to determine whether the iPad2(®) can cause ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The New England journal of medicine
دوره 360 9 شماره
صفحات -
تاریخ انتشار 2003